All News
Filter News
Found 808,690 articles
-
Honor The Veterinary Heroes In Your Animal's Life!
1/16/2019
Nominations now open for 2019 American Humane Hero Veterinarian and Hero Veterinary Nurse Awards™, sponsored by Zoetis Petcare; Winners to be featured in national television broadcast
-
Paladina Health Acquires Activate Healthcare to Amplify Impact of Primary Care Nationwide
1/16/2019
Organizations Join Forces to Expand Delivery of Personalized, Innovative Care Models
-
Data Suggest That Men Should Resolve to Address Their BPH Symptoms in 2019
1/16/2019
NeoTract Study Finds That Men Over 40 Are Not Aware that Delaying Treatment of Benign Prostatic Hyperplasia (BPH) Can Cause Permanent Bladder Damage or of Treatment Options
-
Arxan Extends Its Leadership Position In Medical Device App Security With Updated Certification To ISO® Standard
1/16/2019
Company Doubles Down on Commitment to Protecting Connected Medical Devices
-
Anika Announces Plans to Showcase HYALOFAST at the International Cartilage Regeneration and Joint Preservation Society (ICRS) Summit in San Diego
1/16/2019
Anika Therapeutics, Inc. announced plans to showcase HYALOFAST, a biodegradable, HA-based cartilage repair scaffold, at the 2019 International Cartilage Repair Society (ICRS) Summit.
-
Patented Medicine Prices Review Board issues a Notice of Hearing for allegations of excessive pricing of Procysbi
1/16/2019
The Patented Medicine Prices Review Board will hold a public hearing in the matter of the price of the patented medicine cysteamine bitartrate, sold under the trade name Procysbi by the patentee Horizon Therapeutics Canada.
-
Medline Selects NICE to Implement Sales Compensation, Territory and Quota Management
1/16/2019
NICE’s Sales Performance Management (SPM) cloud-based solution to manage planning and execution of sales compensation for over 1,600 direct sales representatives across the United States
-
NMS Labs and PinneyAssociates Announce Collaborative Agreement to Provide In Vitro Abuse-Deterrent Assessment Services
1/16/2019
NMS Labs and PinneyAssociates have established a collaborative agreement to provide comprehensive guidance on and implementation of in vitro assessment of abuse-deterrent drugs and formulations for pharmaceutical companies developing drugs that act on the central nervous system.
-
Experimental Treatment Approach Shows Potential against Staphylococcus aureus
1/16/2019
A new class of engineered proteins may counter infection caused by Staphylococcus aureus – a bacterial species considered one of the largest global health threats, a new study suggests.
-
New INGREZZA® (valbenazine) Analysis Published in the Journal of Affective Disorders Demonstrates Sustained Improvement in Tardive Dyskinesia Symptoms in Patients with Primary Mood Disorders
1/16/2019
INGREZZA Significantly Reduced the Symptoms of Involuntary Movements in Patients with Bipolar or Major Depressive Disorder in Post-Hoc Analysis
-
Sandoz Inc. launches SYMJEPI™ (epinephrine) in the US
1/16/2019
Sandoz Inc. (Sandoz), a Novartis division, announced the US market introduction of SYMJEPI™ (epinephrine) 0.3 mg Injection for the emergency treatment of allergic reactions (Type 1), including anaphylaxis.
-
Juvenescence Closes First Tranche of Series B Enabling Further Growth and Development
1/16/2019
Juvenescence Ltd, a biopharmaceutical company focused on modifying ageing and age-related disease, is pleased to announce the close of the first tranche of its Series B financing, in the amount of $46 million
-
vTv Therapeutics Announces Publication of Comprehensive Data in Science Translational Medicine Detailing the Discovery and Clinical Development of TTP399, including Results of Phase 2 AGATA Study
1/16/2019
Results Found TTP399 Demonstrated a Statistically Significant Improvement in HbA1c Compared to Placebo without Hypoglycemia or Hyperlipidemia
-
First Patients in the Middle East Treated with Cardiovascular Systems, Inc. Diamondback 360® Coronary Orbital Atherectomy System
1/16/2019
Introduction of Orbital Atherectomy in the Middle East by OrbusNeich® Expands Treatment Options for Patients with Complex Coronary Artery Disease
-
Actelion Receives Complete Response Letter from U.S. FDA for OPSUMIT® (Macitentan) Supplemental New Drug Application
1/16/2019
Actelion Pharmaceuticals Ltd announced it has received a complete response letter from the U.S. Food and Drug Administration (FDA) for its supplemental New Drug Application (sNDA) for OPSUMIT® (macitentan) in the treatment of adults with inoperable chronic thromboembolic pulmonary hypertension (CTEPH, WHO Group 4) to improve pulmonary vascular resistance (PVR) and exercise capacity.
-
Omron® HeartGuide™, the first wearable blood pressure monitor, a top award-winner at CES 2019
1/16/2019
The new Omron Healthcare blood pressure monitor in the design of a wrist watch honored with top awards for wearables, health tech, and innovation at world's largest annual technology innovation show
-
Luye Pharma Reaches Strategic Partnership with AstraZeneca, Strengthens Commitment to Cardiovascular Therapeutic Field
1/16/2019
Luye Pharma grants AstraZeneca exclusives rights to promote Xuezhikang Capsules in mainland China
-
Science Translational Medicine Publishes First-in-Human Clinical Data and Supporting Preclinical Data for SYNB1020, Synlogic’s Synthetic Biotic™ Medicine in Development as a Potential Treatment for Hyperammonemia
1/16/2019
Phase 1 clinical trial to evaluate safety and tolerability of SYNB1020 in healthy volunteers demonstrated safety, clearance and proof of mechanism
-
Solidarity HealthShare, Major Sponsor of 2019 March For Life, Honors Physician Who Helped Champion New Abortion Pill Reversal Procedure
1/16/2019
Solidarity HealthShare, Which Provides a Pro-Life Alternative to Traditional Health Insurance Applauds Life Saving Procedure that Shows a 68% Success Rate
-
Consumer Health Tech Company Ciitizen™ Raises $17M in Series A Financing to Accelerate Data Platform Development and Commercialization
1/16/2019
Financing led by Andreessen Horowitz with Participation from Section 32 and Verily